Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)

NCT00265330 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Ziprasidone oral capsules

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.